Dose-dependent increases in lean body mass in healthy young men over 21 days, with no change in prostate-specific antigen.
View on PubMed →
LGD Solution
Tax included where applicable. Shipping calculated at checkout.
LGD-4033 (Ligandrol) is a non-steroidal selective androgen receptor modulator (SARM) and one of the most clinically studied compounds in its class. In a Phase I clinical trial, LGD-4033 produced dose-dependent increases in lean body mass over 21 days in healthy young men, with a favourable safety profile.
Every batch is independently tested by a 3rd party laboratory. Certificate of Analysis available below.
The more you buy, the more you save
Every batch is tested by an independent third-party laboratory with no commercial relationship to Camo Chem. We never self-certify. The full Certificate of Analysis is published on this page and verifiable directly with the testing lab.
Worldwide shipping. UK orders typically delivered in 1-3 working days. EU and international orders 3-7 working days. Tracked and signed-for delivery. Free shipping over £65 (UK) / €110 (EU) / $110 (US).
Store in a cool, dry place away from direct sunlight. Keep the bottle tightly sealed.
About this compound
What does the research say?
LGD-4033 is one of the few SARMs to have completed multiple stages of clinical evaluation. In a Phase I trial involving 76 healthy young men, doses of 0.1mg, 0.3mg, and 1.0mg daily for 21 days produced statistically significant, dose-dependent increases in lean body mass. The 1.0mg group gained an average of 1.21 kg of lean mass in just three weeks with no significant change in PSA, haematocrit, or liver enzymes.
A Phase II clinical trial (VK5211) evaluated LGD-4033 in 120 patients recovering from hip fracture, demonstrating improvements in lean body mass and functional measures of muscle strength.
These are not marketing claims. These are peer-reviewed, published results. You can verify every reference below.
Why does quality matter with LGD-4033?
LGD-4033 is frequently counterfeited or substituted with cheaper compounds. Without independent third-party testing, there is no way to confirm that a product labelled as LGD-4033 actually contains the correct compound at the stated concentration.
At Camo Chem, every batch is tested by an independent 3rd party laboratory. We publish the full Certificate of Analysis for every batch, and you can verify the results directly with the lab. We do not self-certify. Ever.
Ask your current supplier: who tests their products?
Compound specifications
| Common Names | Ligandrol, LGD-4033, LGD4033, VK5211 |
| CAS Number | 1165910-22-4 |
| Molecular Formula | C₁₄H₁₂F₆N₂O |
| Molecular Weight | 338.25 g/mol |
| PubChem CID | 44137686 |
| Classification | Non-steroidal SARM |
| Purity | ≥98% (HPLC verified) |
| Form & Concentration | Solution in PEG-400/DMSO, 20mg/ml, 30ml bottle |
| Ingredients | PEG-400, DMSO, LGD-4033 |
| Storage | Cool, dry place. Keep sealed. Avoid direct sunlight. |
Published research on LGD-4033
1.0mg daily produced an average gain of 1.21 kg lean mass in 3 weeks in a Phase I clinical trial.
View on PubMed →Phase II trial in hip fracture patients showed improvements in lean body mass and muscle strength measures.
View on PubMed →What researchers are saying
To keep it short, it works.
Frequently asked questions
LGD-4033 is a non-steroidal selective androgen receptor modulator (SARM) with CAS number 1165910-22-4. It is one of the most clinically studied SARMs, with published Phase I and Phase II trial data. It is sold exclusively as a research compound.
Every batch meets a minimum of 98% purity as verified by HPLC. Testing is performed by an independent 3rd party laboratory. The Certificate of Analysis is available on this page and can be verified directly with the lab.
By an independent laboratory with no commercial relationship with our company. We do not self-certify. Many competitors issue their own Certificates of Analysis, which provides no real quality guarantee. Our CoAs are verifiable directly with the testing lab.
LGD-4033 has been evaluated in a Phase I trial in healthy men (Basaria et al., 2013) and a Phase II trial in hip fracture patients (VK5211). Both trials are published or registered in public clinical trial databases.
Store in a cool, dry place away from direct sunlight. Keep the bottle tightly sealed.